The generic drugs market has emerged as a critical segment of the pharmaceutical industry, offering affordable alternatives to branded medications. As of 2023, the market value stood at nearly USD 434.45 billion, driven by a surge in cardiometabolic risk factors worldwide. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 5.5% expected...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek